Sybil Dahan. Photo: Abbott Scandinavia
CEO of health and pharmaceutical company Abbott Scandinavia, Sybil Dahan, is leaving her post at the end of May. Camilla Soenderby has been selected to replace Dahan, who leaves Sweden to assume the position of Commercial Director of the therapy area Immunology in Montreal with Abbott Canada. Soenderby joins Abbott Scandinavia from Schering-Plough, where she was President of the company’s business in Taiwan.